Kathryn Romano, Chief Accounting Officer at Krystal Biotech, Inc. (KRYS), sold 25,254 shares at $270.56 ($6.7M) on 2026-02-09, disclosed to the SEC on 2026-02-11.
Seasonal sale ($6.7M) by Chief Accounting Officer — this insider has traded KRYS in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 750 | $0 | 0.0% |
| 2 | $270.56 | 2,000 | $541K | 8.1% |
| 3 | $270.56 | 2,000 | $541K | 8.1% |
| 4 | $271.66 | 5,700 | $1.5M | 23.2% |
| 5 | $271.66 | 5,700 | $1.5M | 23.2% |
| 6 | $272.51 | 2,824 |
| $770K |
| 11.5% |
| 7 | $272.51 | 2,824 | $770K | 11.5% |
| 8 | $273.71 | 928 | $254K | 3.8% |
| 9 | $273.71 | 928 | $254K | 3.8% |
| 10 | $274.64 | 552 | $152K | 2.3% |
| 11 | $274.64 | 552 | $152K | 2.3% |
| 12 | $275.68 | 400 | $110K | 1.7% |
| 13 | $277.88 | 96 | $27K | 0.4% |
| Total | $263.98 avg | 25,254 | $6.7M | 100% |
| Filing → |
| KRYS | SELL | 2024-03-01 | $1.8M | — | Filing → |
| KRYS | SELL | 2024-03-01 | $1.4M | — | Filing → |
| KRYS | SELL | 2024-02-28 | $1.1M | — | Filing → |